Maternal-fetal medicine specialist Todd Rosen, MD, discusses how quitting smoking during pregnancy affects risks of preterm birth, stillbirth, and preeclampsia, urging simultaneous focus on nutrition to optimize outcomes.

A comprehensive analysis reveals rising hospitalization rates among pregnant women with hepatitis C virus, with age as a critical factor influencing maternal and fetal health outcomes.

A study revealed that midwifery-model care significantly reduces postpartum emergency department visits compared to obstetrics care, offering insights into improving maternal healthcare access.

A recent study revealed an association between premature menopause and increased risks of musculoskeletal pain and sarcopenia, emphasizing the potential benefits of hormone therapy in mitigating long-term effects.

Explore how robotic surgery revolutionizes obstetric and gynecologic procedures, offering enhanced precision, reduced complications, and improved patient outcomes, while also examining challenges and future prospects in the field.

Recent research suggests assessing recent opioid use could aid in managing anxiety related to abortion, shedding light on pain management strategies for providers and patients alike.

The United States Preventive Services Task Force has announced new recommendations for breast cancer screenings. Find out what this means for your patients and your practice.

Discover the benefits of regular exercise during pregnancy, from reducing risks of adverse outcomes to improving psychologic symptoms, as discussed by Gabriela Dellapiana, MD, maternal-fetal medicine physician at Cedars-Sinai Medical Center.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A study highlighted how non-English-speaking patients undergoing gynecologic surgery face undertreated pain, emphasizing the need for equitable pain management practices.

A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.

Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.

Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.

A recent study revealed a significant increase in intrauterine device usage among reproductive-aged women in South Carolina following the implementation of the Choose Well initiative.

A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.

A recent poll highlights increasing public demand for broader insurance coverage for in vitro fertilization, underscoring persistent barriers faced by millions without access to adequate fertility care.

Explore the efficacy of Pivya (pivmecillinam; Utility Therapeutics) tablets in managing uncomplicated urinary tract infections in female adults, supported by controlled clinical trials and safety considerations.

Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.

A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.

Explore the latest Commonwealth Fund report revealing persistent racial inequities in health care access and outcomes, prompting urgent calls for targeted policy interventions and systemic reform.

Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.

A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.

A recent study explored the correlation between placental histologic types and recurrent preterm birth risk, shedding light on potential predictive factors for obstetric outcomes.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study delved into the intricate clusters of term preeclampsia, shedding light on its diverse manifestations and the pivotal role of intravascular inflammation, paving the way for improved classification and management strategies.